Back to 
Sanders Capital, LLC
Sanders Capital, LLC
AZN2 quarters
Position history for Sanders Capital, LLC's holdings in ASTRAZENECA PLC
Yes. Sanders Capital holds 6,986,830 shares of AZN (AstraZeneca), worth $1.3B, as of its Q2 2026 13F filing. It reduced the position by 78,798 shares (-1.1%) from Q1 2026. Sanders Capital has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 1.3% of Sanders Capital's reported 13F portfolio.
Current Value
$1.3B
Current Shares
7M
Total Value Change
-$68.6M
Total Shares Change
-78,798
Quarter-by-Quarter History
Other major holders of AZN: VANGUARD CAPITAL MANAGEMENT LLC, Capital International Investors, NORGES BANK